|
审核状态: Project audit state: |
通过审核 Successful |
|
注册号: Registration number: |
ChiCTR2500112496 |
|
最近更新日期: Date of Last Refreshed on: |
2025-11-14 16:34:45 |
|
注册时间: Date of Registration: |
2025-11-14 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
医用外科口罩预防呼吸道病原体传播、感染的有效性:以家庭为单位的整群随机对照试验 |
|
Public title: |
Effectiveness of Surgical Masks in Preventing Household Transmission of Respiratory Viral Infections: A Cluster-Randomized Controlled Trial in Community Settings |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
医用外科口罩预防呼吸道病原体传播、感染的有效性:以家庭为单位的整群随机对照试验 |
|
Scientific title: |
Effectiveness of Surgical Masks in Preventing Household Transmission of Respiratory Viral Infections: A Cluster-Randomized Controlled Trial in Community Settings |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
沈莹 |
研究负责人: |
沈莹 |
|
Applicant: |
Ying Shen |
Study leader: |
Ying Shen |
|
申请注册联系人电话: Applicant telephone: |
+86 188 1118 1087 |
研究负责人电话:
Study leader's |
+86 188 1118 1087 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
amandashy@163.com |
研究负责人电子邮件: Study leader's E-mail: |
amandashy@163.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
北京市和平里中街39号 |
研究负责人通讯地址: |
北京市和平里中街39号 |
|
Applicant address: |
No. 39, Hepingli Middle Street, Dongcheng District, Beijing |
Study leader's address: |
No. 39, Hepingli Middle Street, Dongcheng District, Beijing |
|
申请注册联系人邮政编码: Applicant postcode: |
100013 |
研究负责人邮政编码: Study leader's postcode: |
100013 |
|
申请人所在单位: |
北京市疾病预防控制中心 |
||
|
Applicant's institution: |
Beijing Center for Disease Prevention and Control |
||
|
研究负责人所在单位: |
北京市疾病预防控制中心 |
||
|
Affiliation of the Leader: |
Beijing Center for Disease Prevention and Control |
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
BJCDC2025033 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
北京市疾病预防控制中心伦理委员会 |
||
|
Name of the ethic committee: |
Ethic Committee of Beijing Center for Disease Prevention and Control |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2025-10-09 00:00:00 | ||
|
伦理委员会联系人: |
邱倩 |
||
|
Contact Name of the ethic committee: |
Qian Qiu |
||
|
伦理委员会联系地址: |
北京市东城区和平里中街39号 |
||
|
Contact Address of the ethic committee: |
No. 39, Hepingli Middle Street, Dongcheng District, Beijing |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 152 0150 7816 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
|
|
研究实施负责(组长)单位: |
北京市疾病预防控制中心 |
||||||||||||||||||||||
|
Primary sponsor: |
Beijing Center for Disease Prevention and Control |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
北京市东城区和平里中街39号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
No. 39, Hepingli Middle Street, Dongcheng District, Beijing |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
科研经费 |
||||||||||||||||||||||
|
Source(s) of funding: |
through program funding. |
||||||||||||||||||||||
|
研究疾病: |
呼吸道传染病 |
||||||||||||||||||||||
|
Target disease: |
respiratory infectious disease |
||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
干预性研究 |
||||||||||||||||||||||
|
Study type: |
Interventional study |
||||||||||||||||||||||
|
研究所处阶段: |
其它 | ||||||||||||||||||||||
|
Study phase: |
N/A |
||||||||||||||||||||||
|
研究设计: |
随机平行对照 |
||||||||||||||||||||||
|
Study design: |
Parallel |
||||||||||||||||||||||
|
研究目的: |
呼吸道感染仍是全球公共卫生领域的核心挑战之一。尤其在季节性流感、新型冠状病毒等呼吸道病毒交替流行的背景下,持续对医疗资源造成压力。这类病毒主要通过飞沫、直接和间接接触、气溶胶传播,口罩作为简便、低成本的非药物干预手段,长期以来被推荐用于阻断病毒传播。然而,关于口罩在非医疗环境中的实际防护效果,目前仍存争议。家庭环境被广泛认为是呼吸道病毒传播最易发生、且传播效率最高的场景。因此,开展以家庭为单位的随机对照试验,明确医用外科口罩在家庭环境中预防呼吸道病原体传播的具体效果,为制定预防常见呼吸道传染病及具有潜在大流行风险的呼吸道病原体流行的防控策略提供科学依据。 |
||||||||||||||||||||||
|
Objectives of Study: |
Respiratory infections remain one of the core challenges in global public health. Particularly under the alternating circulation of respiratory viruses such as seasonal influenza and novel coronaviruses, these infections continue to exert substantial pressure on healthcare systems. Such viruses are primarily transmitted via droplets, direct and indirect contact, and aerosols. As a simple and low-cost non-pharmaceutical intervention, mask use has long been recommended to interrupt viral transmission. However, the actual protective effectiveness of masks in non-medical community settings remains controversial. The household setting is widely recognized as one of the most favorable environments for respiratory virus transmission, with high efficiency of spread. Therefore, conducting a randomized controlled trial at the household level to determine the specific effectiveness of medical surgical masks in preventing the transmission of respiratory pathogens within households will provide scientific evidence for developing prevention and control strategies against common respiratory infectious diseases and emerging pathogens with pandemic potential. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
1.北京市常住居民(居住>=6个月); 2.指示病例于就诊前3天出现符合ILI定义的症状(体温>=38℃,伴咳嗽或咽痛之一); 3. 指示病例经多重PCR检测,至少确诊感染一种急性呼吸道病原体(流感、SARS-CoV-2、RSV、HPIV、腺病毒、鼻病毒、普通冠状病毒、偏肺病毒、肺炎支原体) 4. 家庭>=2人,且无5岁及以下儿童; 5. 所有家庭成员愿意配合干预、采样并签署知情同意书。 |
||||||||||||||||||||||
|
Inclusion criteria |
1. Permanent residents of Beijing (living >=6 months); 2. The index case developed symptoms meeting the ILI definition (temperature >=38℃ with either cough or sore throat) within 3 days before seeking medical care; 3. The index case was tested by multiple PCR assays and confirmed to be infected with at least one acute respiratory pathogen (influenza, SARS-CoV-2, RSV, HPIV, adenovirus, rhinovirus, common coronavirus, human metapneumovirus, or Mycoplasma pneumoniae); 4. Household of >=2 people, with no children aged 5 years or younger; 5. All household members are willing to cooperate with interventions, sampling, and sign informed consent forms. |
||||||||||||||||||||||
|
排除标准: |
1.指示病例发病超过3天 ; 2.指示病例发病前一周至现在,家庭成员曾出现满足符合呼吸道疾病定义的症状; 3.指示病例或家庭成员存在严重精神障碍或呼吸系统疾病等无法配合佩戴口罩; 4.非北京市常住居民; 5.拒绝参与干预和样本采集的个体 . |
||||||||||||||||||||||
|
Exclusion criteria: |
1. The index case has been ill for more than 3 days; 2. From one week before the onset of the index case to the present, family members have shown symptoms that meet the definition of a respiratory disease; 3. The index case or family members have severe mental disorders or respiratory system diseases that prevent them from wearing a mask properly; 4. Non-permanent residents of Beijing; 5. Individuals who refuse to participate in interventions and sample collection. |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2025-11-17 00:00:00至 To 2026-05-31 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2025-12-01 00:00:00 至 To 2026-05-31 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
尚未开始 Not yet recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
本研究在家庭为单位进行随机分组,采用区块随机化方法,区块大小为 6,以保证三组(A、B、C)在每个区块内人数相对平衡。每个区块内各组受试者人数固定(每组 2 人),具体分配顺序通过计算机随机生成,由独立研究人员负责生成随机序列。 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
This study performed random grouping at the household level using a block randomization method with a block size of 6 to ensure that the number of participants in the three groups (A, B, C) was relatively balanced within each block. The number of participants in each group within a block was fixed (2 per group), and the specific allocation order was randomly generated by a computer and managed by an independent researcher. |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
公开/Public |
|
盲法: |
无 |
|
Blinding: |
None |
|
试验完成后的统计结果(上传文件): |
|
|
Calculated Results after
|
|
|
是否共享原始数据: IPD sharing |
否No |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
无 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
None |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
数据通过纸制的问卷采集,专人管理 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
Data will be collected using paper-based questionnaires and managed by dedicated personnel. |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
暂未确定/Not yet |